background
communityacquir
pneumonia
cap
lead
caus
hospit
mortal
children
diagnosi
remain
challeng
reliabl
tool
object
risk
stratifi
patient
predict
clinic
outcom
molecular
distanc
health
mdth
genom
score
measur
global
perturb
transcript
profil
may
help
classifi
patient
diseas
sever
evalu
valu
mdth
assess
diseas
sever
children
hospit
cap
method
children
hospit
cap
match
healthi
control
enrol
prospect
observ
studi
blood
sampl
obtain
transcriptom
analys
within
h
hospit
mdth
score
calcul
assess
diseas
sever
correl
laboratori
marker
white
blood
cell
count
creactiv
protein
crp
procalcitonin
pct
clinic
outcom
includ
durat
fever
durat
hospit
lo
univari
multivari
logist
regress
appli
assess
factor
associ
lo
durat
fever
hospit
result
among
children
hospit
cap
n
pyogen
bacteria
pb
detect
mycoplasma
pneumonia
detect
respiratori
virus
rv
alon
detect
pathogen
detect
children
statist
group
comparison
identifi
gene
differenti
express
patient
cap
vs
healthi
control
n
children
confirm
pb
higher
mdth
score
rv
p
pneumonia
p
detect
alon
crp
r
p
pct
r
p
mdth
r
p
correl
durat
fever
mdth
correl
lo
r
p
unadjust
analys
show
higher
crp
mdth
associ
longer
lo
respect
howev
mdth
remain
signific
adjust
covari
aor
wallihan
et
al
mdth
score
pediatr
cap
conclus
children
hospit
cap
mdth
score
measur
within
h
admiss
independ
associ
longer
durat
hospit
regardless
pathogen
detect
suggest
transcript
biomark
may
repres
promis
approach
assess
diseas
sever
children
cap
background
communityacquir
pneumonia
cap
lead
caus
hospit
mortal
children
diagnosi
remain
challeng
reliabl
tool
object
risk
stratifi
patient
predict
clinic
outcom
molecular
distanc
health
mdth
genom
score
measur
global
perturb
transcript
profil
may
help
classifi
patient
diseas
sever
evalu
valu
mdth
assess
diseas
sever
children
hospit
cap
method
children
hospit
cap
match
healthi
control
enrol
prospect
observ
studi
blood
sampl
obtain
transcriptom
analys
within
h
hospit
mdth
score
calcul
assess
diseas
sever
correl
laboratori
marker
white
blood
cell
count
creactiv
protein
crp
procalcitonin
pct
clinic
outcom
includ
durat
fever
durat
hospit
lo
univari
multivari
logist
regress
appli
assess
factor
associ
lo
durat
fever
hospit
result
among
children
hospit
cap
n
pyogen
bacteria
pb
detect
mycoplasma
pneumonia
detect
respiratori
virus
rv
alon
detect
pathogen
detect
children
statist
group
comparison
identifi
gene
differenti
express
patient
cap
vs
healthi
control
n
children
confirm
pb
higher
mdth
score
rv
p
pneumonia
p
detect
alon
crp
r
p
pct
r
p
mdth
r
p
correl
durat
fever
mdth
correl
lo
r
p
unadjust
analys
show
higher
crp
mdth
associ
longer
lo
respect
howev
mdth
remain
signific
adjust
covari
aor
conclus
children
hospit
cap
mdth
score
measur
within
h
admiss
independ
associ
longer
durat
hospit
regardless
pathogen
detect
suggest
transcript
biomark
may
repres
promis
approach
assess
diseas
sever
children
cap
keyword
pediatr
pneumonia
transcript
profil
analysi
gene
express
profil
biomark
communityacquir
pneumonia
background
industri
countri
communityacquir
pneumonia
cap
annual
incid
per
children
age
year
per
children
year
age
although
mortal
reach
level
report
develop
world
signific
morbid
financi
burden
associ
pneumonia
unit
state
second
injuri
common
reason
hospit
children
year
age
nation
center
health
statist
recent
data
report
overal
incid
case
per
children
incid
case
per
children
age
two
jain
et
al
despit
high
incid
diagnosi
manag
pediatr
cap
remain
signific
challeng
clinician
first
specif
etiolog
identifi
mani
case
wubbel
et
al
et
al
toikka
et
al
moulin
et
al
korppi
michelow
et
al
et
al
make
target
therapi
difficult
addit
clinic
featur
cap
variabl
may
overlap
respiratori
diseas
asthma
bronchiol
margoli
gadomski
lynch
et
al
make
appropri
triag
children
cap
problemat
mani
case
current
reliabl
tool
object
classifi
patient
accord
diseas
sever
predict
patient
develop
complic
need
higher
level
care
fact
guidelin
diagnosi
manag
cap
children
propos
number
area
futur
research
includ
definit
risk
factor
respiratori
failur
hospit
develop
new
diagnost
test
determin
etiolog
cap
assess
diseas
sever
respons
therapi
bradley
et
al
major
studi
appli
transcript
profil
analysi
children
infecti
diseas
focus
abil
tool
aid
establish
etiolog
diagnosi
infect
number
studi
conduct
febril
children
bacteri
viral
infect
show
transcript
profil
differenti
viral
bacteri
infect
accuraci
ramilo
et
al
herberg
et
al
mahajan
et
al
regardless
anoth
potenti
applic
transcript
profil
biomark
clinic
set
abil
help
assess
diseas
activ
diseas
sever
object
manner
chaussabel
et
al
mejia
et
al
molecular
distanc
health
mdth
novel
metric
tool
provid
singl
numer
score
summar
global
perturb
transcript
profil
patient
compar
healthi
control
refer
standard
pankla
et
al
shown
accur
classifi
sever
diseas
patient
bacteri
sepsi
pankla
et
al
staphylococc
infect
banchereau
et
al
well
children
respiratori
viral
infect
mejia
et
al
heinonen
et
al
hypothesi
transcript
profil
specif
mdth
score
would
serv
accur
biomark
diseas
sever
children
hospit
cap
observ
studi
involv
conveni
sampl
previous
healthi
children
hospit
cap
nationwid
children
hospit
nch
columbu
ohio
februari
may
patient
review
elig
time
admiss
hospit
inclus
criteria
includ
age
month
year
evid
acut
infect
sign
symptom
respiratori
ill
radiolog
confirm
lower
respiratori
tract
diseas
exclus
criteria
includ
signific
preexist
medic
condit
use
immunomodulatori
agent
prematur
week
subject
younger
year
age
primari
diagnosi
bronchiol
supplement
tabl
includ
inclus
exclus
criteria
enrol
complet
sampl
obtain
within
h
admiss
healthi
control
enrol
outpati
routin
visit
minor
elect
surgic
procedur
involv
respiratori
tract
healthi
control
group
clinic
questionnair
use
children
comorbid
use
system
steroid
presenc
ill
within
week
prior
enrol
exclud
written
inform
consent
obtain
parentsguardian
enrol
accord
declar
helsinki
nch
institut
review
board
irb
approv
studi
nch
irb
standard
care
children
hospit
cap
nch
studi
period
includ
blood
cultur
complet
blood
count
cbc
creactiv
protein
crp
nasopharyng
np
swab
viral
detect
via
direct
fluoresc
antibodi
dfa
includ
influenza
b
parainfluenza
adenoviru
rsv
millipor
billerica
unit
state
human
metapneumoviru
hmpv
diagnost
hybrid
athen
oh
unit
state
polymeras
chain
reaction
pcr
np
andor
oropharyng
op
swab
mycoplasma
pneumonia
figur
flow
chart
depict
studi
popul
consort
diagram
enrol
exclus
final
cohort
subject
noninfecti
diagnos
inadequ
unavail
rna
sampl
exclud
analys
one
child
concomit
detect
pneumonia
pneumonia
parainfluenza
viru
categor
pyogen
bacteria
group
analys
detect
pcr
pleural
fluid
obtain
per
standard
care
sampl
analyz
routin
bacteri
cultur
pcr
assay
streptococcu
pneumonia
streptococcu
pyogen
pneumonia
realtim
pcr
pneumonia
perform
lightcycl
r
roch
diagnost
indianapoli
unit
state
use
laboratori
develop
assay
modifi
saukkoriipi
et
al
target
bp
segment
pneumolysin
pli
gene
marcon
et
al
yu
et
al
pyogen
pneumonia
pcr
perform
abi
realtim
pcr
system
appli
biosystem
carlsbad
ca
unit
state
use
separ
laboratorydevelop
assay
pyogen
assay
target
bp
segment
pyrogen
exotoxin
b
speb
gene
marcon
et
al
pneumonia
assay
target
bp
segment
adhesin
protein
gene
hardegg
et
al
addit
sampl
obtain
routin
clinic
care
addit
blood
sampl
obtain
measur
procalcitonin
pct
concentr
pneumonia
pyogen
identif
pcr
procalcitonin
measur
use
vida
r
platform
biomerieux
durham
nc
blood
pcr
pct
assay
perform
batch
discharg
therefor
avail
clinic
decisionmak
addit
test
np
specimen
dfa
pcr
per
standard
care
describ
np
specimen
also
analyz
use
xtag
r
rvp
rvp
fast
multiplex
assay
luminex
austin
tx
unit
state
includ
detect
virus
respiratori
syncyti
viru
rsv
b
influenza
nonspecif
influenza
b
parainfluenza
viru
piv
hmpv
rhinovirusenteroviru
rv
adenoviru
adv
coronaviru
sar
human
bocaviru
hbv
purpos
transcript
profil
analysi
children
categor
four
group
accord
detect
viral
bacteri
pathogen
pyogen
bacteria
pneumonia
respiratori
virus
undetermin
patient
includ
pyogen
bacteria
group
bacteri
pathogen
identifi
cultur
pcr
blood
pleural
fluid
without
concomit
detect
respiratori
viru
pneumonia
np
specimen
patient
includ
pneumonia
group
posit
pcr
result
np
op
specimen
without
concomit
respiratori
viru
patient
includ
respiratori
viru
group
posit
result
viral
assay
perform
standard
care
research
purpos
without
detect
pyogen
bacteria
pneumonia
final
patient
classifi
undetermin
pathogen
detect
sinc
current
standard
microbiolog
diagnost
method
limit
especi
detect
bacteri
pathogen
blood
cultur
lack
adequ
sensit
acknowledg
group
alloc
base
pathogen
detect
suboptim
nevertheless
studi
focus
identif
biomark
assess
diseas
sever
instead
defin
pathogenspecif
diagnost
biosignatur
electron
healthcar
record
review
demograph
clinic
laboratori
radiograph
data
durat
fever
hospit
temperatur
c
day
respiratori
support
supplement
oxygen
noninvas
ventil
intub
durat
hospit
lo
use
clinic
marker
diseas
sever
major
studi
period
standard
discharg
criteria
institut
decis
discharg
made
discret
attend
physician
whole
blood
sampl
ml
microarray
analys
patient
ageand
sexmatch
healthi
control
collect
tempu
tube
appli
biosystem
ca
pneumonia
detect
alon
p
p
p
respect
well
higher
crp
pct
children
pathogen
detect
group
p
p
respect
h
mdth
score
significantli
higher
pneumonia
group
compar
healthi
control
p
sampl
signal
intens
genespr
gx
agil
technolog
palo
alto
ca
unit
state
softwar
perform
normal
analys
allantaz
et
al
ramilo
et
al
berri
et
al
briefli
transcript
first
select
present
least
sampl
minimum
twofold
express
chang
compar
median
intens
across
sampl
transcript
pass
filter
includ
qualiti
control
qc
gene
list
use
downstream
analys
first
conduct
class
comparison
compar
analys
predefin
sampl
group
analys
pathogendetect
group
pyogen
bacteria
pneumonia
without
respiratori
virus
purpos
class
comparison
respiratori
virus
compar
separ
healthi
control
group
use
mannwhitney
p
benjaminihochberg
multipl
test
correct
fold
chang
express
level
rel
control
group
berri
et
al
mejia
et
al
goal
initi
analys
identifi
gene
significantli
differenti
express
three
group
patient
cap
compar
healthi
control
aid
calcul
mdth
score
next
calcul
mdth
score
metric
convert
global
transcript
perturb
measur
patient
sampl
numer
valu
incorpor
analys
clinic
variabl
analysi
consist
compar
express
valu
significantli
differenti
underexpress
gene
fold
differ
express
valu
mdth
score
individu
pneumonia
patient
vs
median
valu
healthi
control
refer
previous
describ
pankla
et
al
berri
et
al
banchereau
et
al
mejia
et
al
data
deposit
gene
express
omnibu
geo
number
bivari
analys
patient
demograph
clinic
characterist
compar
use
chisquar
fisher
exact
test
appropri
normal
distribut
continu
variabl
compar
use
ttest
one
way
anova
result
express
mean
standard
deviat
sd
nonnorm
distribut
continu
variabl
compar
use
mannwhitney
kruskalw
test
result
express
median
interquartil
rang
iqr
univari
multivari
logist
regress
use
assess
factor
associ
three
major
outcom
care
durat
fever
durat
respiratori
support
total
durat
stay
lo
allow
better
clinic
interpret
outcom
dichotom
median
lo
day
respiratori
support
durat
fever
hospit
day
covari
p
univari
analysi
includ
multivari
model
analys
conduct
use
sa
sa
institut
cari
nc
unit
state
one
hundr
eightyeight
previous
healthi
children
hospit
cap
enrol
februari
may
five
children
later
exclud
due
noninfecti
diagnos
remain
patient
whole
blood
sampl
avail
success
underw
transcript
profil
analysi
patient
match
healthi
control
age
sex
race
also
enrol
part
studi
pyogen
bacteria
without
respiratori
virus
detect
children
includ
one
child
concomit
detect
pneumonia
pneumonia
parainfluenza
viru
pneumonia
without
respiratori
virus
detect
children
respiratori
virus
alon
detect
children
seventeen
children
pathogen
detect
figur
summar
enrol
pathogen
detect
demograph
laboratori
clinic
data
patient
healthi
control
summar
tabl
children
pneumonia
group
older
children
respiratori
viru
group
p
signific
differ
respect
age
gender
race
among
group
total
children
admit
picu
requir
mechan
ventil
addit
requir
noninvas
ventil
streptococcu
pneumonia
n
frequent
pyogen
bacterium
detect
follow
pyogen
n
aureu
n
children
test
respiratori
virus
virus
detect
children
shown
figur
rhinovirusenteroviru
n
frequent
viru
detect
follow
rsv
n
parainfluenza
viru
n
human
metapneumoviru
n
viru
detect
multipl
virus
detect
children
statist
group
comparison
identifi
differenti
express
transcript
children
pyogen
bacteria
cap
healthi
control
transcript
detect
pneumonia
healthi
control
transcript
children
detect
respiratori
virus
healthi
control
combin
gene
deriv
pairwis
comparison
result
total
gene
differenti
express
children
cap
detect
pathogen
figur
gene
share
among
pathogen
group
specif
pyogen
bacteria
specif
respiratori
virus
specif
pneumonia
gene
list
gene
use
calcul
mdth
score
mdth
score
significantli
higher
pneumonia
group
compar
healthi
control
p
tabl
children
detect
pyogen
bacteria
higher
mdth
crp
pct
valu
detect
respiratori
virus
p
p
p
respect
pneumonia
detect
alon
p
p
p
respect
well
higher
crp
pct
children
pathogen
detect
group
p
p
respect
addit
children
mdth
score
median
valu
mdth
like
prescrib
cours
antibiot
mdth
score
median
vs
p
white
blood
cell
count
time
admiss
hospit
differ
among
group
correl
clinic
marker
diseas
sever
includ
day
respiratori
support
day
fever
hospit
lo
howev
crp
r
p
pct
r
p
mdth
r
p
measur
admiss
correl
day
fever
hospit
supplement
figur
univari
analys
mdth
score
measur
admiss
correl
lo
n
r
p
figur
analysi
identifi
three
clinic
outcom
day
respiratori
support
durat
fever
durat
hospit
stay
lo
day
respiratori
support
variabl
interest
signific
univari
analys
multivari
analysi
perform
tabl
show
result
unadjust
adjust
analys
durat
fever
hospit
dichotom
day
base
median
durat
fever
univari
analys
higher
mdth
significantli
associ
longer
durat
fever
associ
signific
multivari
assess
regard
longer
lo
also
dichotom
median
univari
analys
show
higher
crp
mdth
score
associ
increas
lo
gender
race
age
wbc
pct
multivari
analys
mdth
biomark
significantli
associ
longer
lo
previou
studi
shown
potenti
valu
transcript
profil
mdth
score
assess
diseas
sever
number
infect
adult
children
studi
includ
patient
infect
singl
bacteri
ie
melioidosi
aureu
tuberculosi
viral
rsv
rhinoviru
pathogen
pankla
et
al
berri
et
al
banchereau
et
al
mejia
et
al
howev
applic
context
pediatr
cap
caus
varieti
respiratori
pathogen
evalu
previous
present
studi
identifi
transcript
score
mdth
score
significantli
correl
inflammatori
marker
wbc
crp
pct
independ
associ
diseas
sever
defin
durat
hospit
children
cap
regardless
pathogen
pathogen
detect
use
current
microbiolog
diagnost
assay
sever
score
system
valid
adult
lower
respiratori
tract
infect
neill
et
al
fine
et
al
lim
et
al
capelastegui
et
al
tool
lack
children
evalu
develop
world
welldefin
criteria
hospit
children
cap
recommend
guidelin
bradley
et
al
also
subject
compon
recent
studi
unit
state
show
promis
result
use
risk
model
combin
patient
laboratori
radiograph
characterist
predict
sever
pneumonia
children
yet
valid
prospect
larger
cohort
william
et
al
multipl
studi
suggest
limit
role
inflammatori
marker
peripher
wbc
count
crp
erythrocyt
sediment
rate
pct
diagnosi
manag
pneumonia
children
difficult
defin
cutoff
valu
sensit
specif
studi
children
cap
et
al
report
higher
pct
level
hospit
patient
compar
outpati
descript
valu
relat
diseas
sever
et
al
recent
lower
pct
valu
associ
reduc
risk
detect
pyogen
bacteria
larg
cohort
children
pneumonia
us
stockmann
et
al
michelow
et
al
examin
level
cytokin
children
cap
found
correl
indic
diseas
sever
michelow
et
al
esposito
colleagu
evalu
role
pctbase
algorithm
guid
antibiot
therapi
children
mildmoder
cap
esposito
et
al
show
applic
algorithm
associ
reduc
antibiot
use
import
evalu
pctbase
algorithm
children
sever
diseas
accur
rapid
identif
children
higher
risk
morbid
need
allow
improv
object
assess
need
hospit
faster
initi
appropri
antimicrobi
therapi
ultim
improv
clinic
outcom
although
present
studi
first
examin
valu
mdth
score
children
cap
tool
appli
patient
popul
varieti
infect
patient
pulmonari
tb
mdth
score
correl
extent
diseas
clinic
improv
therapi
berri
et
al
patient
aureu
infect
mdth
correl
laboratori
paramet
crp
wbc
neutrophil
count
show
increas
valu
diseas
dissemin
banchereau
et
al
mdth
score
also
evalu
infant
children
respiratori
infect
caus
rsv
rhinoviru
mejia
et
al
heinonen
et
al
jong
et
al
children
rsv
infect
mdth
score
admiss
correl
clinic
diseas
sever
score
well
durat
supplement
oxygen
durat
hospit
addit
mdth
score
decreas
followup
visit
demonstr
potenti
util
monitor
respons
therapi
mejia
et
al
applic
mdth
score
children
detect
rhinoviru
pcr
allow
discrimin
children
symptomat
respiratori
infect
vs
asymptomat
detect
heinonen
et
al
present
studi
number
strength
first
includ
patient
broad
rang
age
increas
generaliz
result
highlight
potenti
impact
mdth
score
pediatr
popul
second
patient
sampl
obtain
within
h
hospit
reduc
potenti
influenc
time
sampl
collect
final
limit
analysi
one
specif
pathogen
class
pathogen
previou
studi
primarili
focus
infect
due
singl
organ
focus
clinic
syndrom
mani
etiolog
agent
thu
addit
variabl
clinic
present
durat
ill
prior
hospit
heterogen
etiolog
cap
howev
despit
factor
still
abl
show
associ
mdth
score
tradit
marker
inflamm
notabl
durat
hospit
studi
also
limit
first
complet
microbiolog
data
lack
patient
furthermor
fact
current
method
bacteri
detect
suboptim
although
patient
classifi
accord
type
pathogen
detect
suspect
pathogen
group
may
includ
misclassifi
patient
especi
true
group
patient
viru
detect
group
may
includ
patient
viralbacteri
coinfect
mention
howev
goal
present
studi
diagnosi
specif
pathogen
discrimin
bacteri
viral
etiolog
rather
identif
biomark
object
assess
diseas
sever
anoth
potenti
limit
healthi
control
comprehens
test
respiratori
pathogen
although
children
current
histori
respiratori
symptom
within
week
exclud
healthi
control
group
addit
analys
correct
durat
ill
prior
hospit
may
caus
variabl
mdth
score
within
pathogen
group
nevertheless
could
also
consid
strength
studi
despit
variabl
durat
symptom
observ
manag
children
cap
clinic
practic
abl
identifi
object
score
classifi
patient
accord
diseas
sever
cohort
includ
hospit
patient
singl
center
central
ohio
futur
studi
includ
ambulatori
hospit
children
divers
geograph
locat
warrant
even
singl
institut
discharg
criteria
standard
major
studi
period
therefor
practic
variabl
among
individu
clinician
may
influenc
durat
hospit
final
obtain
sampl
directli
lower
respiratori
tract
minor
patient
requir
invas
ventil
support
thu
data
peripher
blood
may
reflect
immun
respons
primari
site
infect
notwithstand
use
blood
sampl
measur
host
respons
respiratori
pathogen
calcul
mdth
score
facilit
implement
clinic
set
summari
initi
studi
suggest
children
cap
mdth
score
may
allow
precis
sever
classif
current
laboratori
marker
routin
applic
tool
may
enhanc
clinic
decis
make
process
provid
object
assess
diseas
sever
futur
studi
warrant
includ
larger
number
children
cap
ambulatori
inpati
set
patient
sever
diseas
admit
picu
combin
mdth
tool
andor
marker
improv
evalu
diseas
sever
data
deposit
gene
express
omnibu
geo
number
portion
work
present
pediatr
academ
societi
meet
washington
dc
may
